Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AGN - Should You Buy AbbVie for the Dividend?


AGN - Should You Buy AbbVie for the Dividend?

AbbVie Inc (NYSE: ABBV) has been on a downward spiral since early 2018. Year to date, the company's share price has decreased by about 26%. This prolonged slump is unprecedented for AbbVie, at least since the firm spun off from Abbott Laboratories (NYSE: ABT). Despite these headwinds, it is hard to ignore AbbVie's stellar dividend history, and its juicy 6.1% dividend. However, a company's ability to sustain its dividends is a function of its earnings prospects. Can AbbVie continue to generate the income necessary to keep its dividends intact

Image source: Getty Images

Humira and beyond 

Continue reading

Stock Information

Company Name: Allergan plc
Stock Symbol: AGN
Market: NYSE
Website: allergan.com

Menu

AGN AGN Quote AGN Short AGN News AGN Articles AGN Message Board
Get AGN Alerts

News, Short Squeeze, Breakout and More Instantly...